EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis

Kaili Du, Hongyu Chen, Zhaonan Pan, Mengli Zhao, Shixue Cheng, Yu Luo, Wenhe Zhang, Dan Li iD

eLife · 04.04.2025 · 13

DOI: 10.7554/elife.103137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 04.04.2025. Verfasst von Kaili Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Techn…. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Niemann-Pick Disease, Type C, Lysosomes, Exocytosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Calygene Biotechnology Inc, Lysoway Therapeutics, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca 2+ -calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsNiemann-Pick Disease, Type CLysosomesExocytosisAnimalsHumansMiceCholesterolIsothiocyanatesCell Line

Stichwörter der Autor:innen

NPC1TFEB agonistscell biologycholesterol accumulationhumanlysosomemouse

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTFEB protein, humanCholesterolTcfeb protein, mouseIsothiocyanates

Autor:innen und Institutionen

  • Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
  • Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, United States.

ORCID-Profile: Dan Li

Förderung

  • National Natural Science Foundation of China
  • Calygene Biotechnology Inc
  • Lysoway Therapeutics, Inc

Zitieren

APA

Du, K., Chen, H., Pan, Z., Zhao, M., Cheng, S., Luo, Y., Zhang, W., & Li, D. (2025). Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis. eLife, 13. https://doi.org/10.7554/elife.103137

Vancouver

Du K, Chen H, Pan Z, Zhao M, Cheng S, Luo Y, et al. Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis. eLife. 2025;13. doi:10.7554/elife.103137

BibTeX
@article{Du2025,
  author = {Du, Kaili and Chen, Hongyu and Pan, Zhaonan and Zhao, Mengli and Cheng, Shixue and Luo, Yu and Zhang, Wenhe and Li, Dan},
  title = {Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis},
  journal = {eLife},
  year = {2025},
  volume = {13},
  doi = {10.7554/elife.103137}
}
Kostenlos starten →